CN1218477A - Organo phosphorous compounds - Google Patents
Organo phosphorous compounds Download PDFInfo
- Publication number
- CN1218477A CN1218477A CN97194522A CN97194522A CN1218477A CN 1218477 A CN1218477 A CN 1218477A CN 97194522 A CN97194522 A CN 97194522A CN 97194522 A CN97194522 A CN 97194522A CN 1218477 A CN1218477 A CN 1218477A
- Authority
- CN
- China
- Prior art keywords
- organic phospho
- phospho acid
- acid compound
- preparing
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000002903 organophosphorus compounds Chemical class 0.000 title description 10
- 229940058344 antitrematodals organophosphorous compound Drugs 0.000 title description 6
- -1 organo phosphonic acids Chemical class 0.000 claims abstract description 37
- 239000002253 acid Substances 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 7
- 229940079593 drug Drugs 0.000 claims abstract description 7
- QQVDJLLNRSOCEL-UHFFFAOYSA-N (2-aminoethyl)phosphonic acid Chemical compound [NH3+]CCP(O)([O-])=O QQVDJLLNRSOCEL-UHFFFAOYSA-N 0.000 claims abstract description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 4
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 150000001875 compounds Chemical class 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 12
- DCAYPVUWAIABOU-UHFFFAOYSA-N alpha-n-hexadecene Natural products CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 5
- 239000000654 additive Substances 0.000 claims description 5
- 230000000996 additive effect Effects 0.000 claims description 5
- 239000012457 nonaqueous media Substances 0.000 claims description 5
- 239000000049 pigment Substances 0.000 claims description 5
- 150000001263 acyl chlorides Chemical class 0.000 claims description 4
- XNRPSTJYNNPDAQ-UHFFFAOYSA-N CC.OC(C(CCCC)P(O)(O)=O)(CC)CC Chemical group CC.OC(C(CCCC)P(O)(O)=O)(CC)CC XNRPSTJYNNPDAQ-UHFFFAOYSA-N 0.000 claims description 3
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- UBNWPQXLFRMMEI-GQCTYLIASA-N 5-[3-[(e)-3-(3-hydroxy-2-methoxycarbonylphenoxy)prop-1-enyl]phenyl]-1,2-oxazole-3-carboxylic acid Chemical compound COC(=O)C1=C(O)C=CC=C1OC\C=C\C1=CC=CC(C=2ON=C(C=2)C(O)=O)=C1 UBNWPQXLFRMMEI-GQCTYLIASA-N 0.000 claims 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000000047 product Substances 0.000 abstract description 29
- 235000015097 nutrients Nutrition 0.000 abstract description 4
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 abstract description 3
- UIQSKEDQPSEGAU-UHFFFAOYSA-N 1-Aminoethylphosphonic Acid Chemical compound CC(N)P(O)(O)=O UIQSKEDQPSEGAU-UHFFFAOYSA-N 0.000 abstract description 2
- 239000007795 chemical reaction product Substances 0.000 abstract description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- NQGIJDNPUZEBRU-UHFFFAOYSA-N dodecanoyl chloride Chemical compound CCCCCCCCCCCC(Cl)=O NQGIJDNPUZEBRU-UHFFFAOYSA-N 0.000 abstract 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 241000251468 Actinopterygii Species 0.000 description 30
- 235000019688 fish Nutrition 0.000 description 30
- 235000013305 food Nutrition 0.000 description 20
- 239000000243 solution Substances 0.000 description 18
- 238000012360 testing method Methods 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 230000035611 feeding Effects 0.000 description 10
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 9
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 9
- 229940022405 astaxanthin Drugs 0.000 description 9
- 235000013793 astaxanthin Nutrition 0.000 description 9
- 239000001168 astaxanthin Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 5
- JJJOZVFVARQUJV-UHFFFAOYSA-N 2-ethylhexylphosphonic acid Chemical compound CCCCC(CC)CP(O)(O)=O JJJOZVFVARQUJV-UHFFFAOYSA-N 0.000 description 4
- 229920001202 Inulin Polymers 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 4
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 4
- 229940029339 inulin Drugs 0.000 description 4
- 230000000474 nursing effect Effects 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000002502 liposome Substances 0.000 description 3
- 235000019476 oil-water mixture Nutrition 0.000 description 3
- PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical compound NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 description 3
- 239000013535 sea water Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 125000005257 alkyl acyl group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 150000004756 silanes Chemical class 0.000 description 2
- TWCMWEWZAVFALI-UHFFFAOYSA-N terrestrosin C Natural products O1C2(OCC(C)CC2)C(C)C(C2(C(=O)CC3C4(C)CC5)C)C1CC2C3CCC4CC5OC(C(C1O)O)OC(CO)C1OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O TWCMWEWZAVFALI-UHFFFAOYSA-N 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 241000277263 Salmo Species 0.000 description 1
- 241000277284 Salvelinus fontinalis Species 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 241000216843 Ursus arctos horribilis Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000011928 denatured alcohol Substances 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- 238000004836 empirical method Methods 0.000 description 1
- PQLFROTZSIMBKR-UHFFFAOYSA-N ethenyl carbonochloridate Chemical compound ClC(=O)OC=C PQLFROTZSIMBKR-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229940061584 phosphoramidic acid Drugs 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/386—Polyphosphonic acids containing hydroxy substituents in the hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Disclosed are organo phosphonic acids having formula (I) where: n = 0 or 1; R1 = H or (a); R2 = (b) or (c); R3 = an alkyl group containing more than 10 carbon atoms; and R4 = H or CH3, that provide improved bio-availability of drugs and nutrients by permiabilising cell membranes. The products are prepared by the method of reacting an acid chloride of long chain aliphatic acid having 10-20 carbon atoms with an alkyl phosphonic acid derivative containing an active amino or hydroxy group in chloroform at temperatures below 5 DEG C. Especially useful are the reaction products of palmitoyl or lauroyl chloride with ethane-1-hydroxy-1,1-diphosphonic acid, 2-amino-ethyl phosphonic acid or 1-amino-ethyl phosphonic acid.
Description
The present invention relates to make the organo phosphorous compounds of medicine and the improvement of nutrient substance bioavailability by saturatingization cytolemma.More particularly described compound can similar lysophospholipid (nanoencapsulation) and the mode of phosphatide seal with the medicine ultra micro that improves nutrient intake, improves the pigment absorption of aquatic products thing and be used for drug release in the donor as animal feedstuff additive." genetically engineered teacher and ergonomist " (the The Genetic Engineer and Biotechnologist) that delivers at David Garnett and Robin Jones, 13 volumes, the 2nd phase, 1993 and International Application No. WO 94/22324 in a kind of mechanism that this bioavailability is improved is proposed.
The compound of the above-mentioned type obtains by natural compounds is purified, and is therefore impure substantially.So when comparing, need high-purity compound (for example can obtain), to improve the thermostability and the antienzyme functionality of compound from chemosynthesis with phosphatide.
Organo phosphorous compounds of the present invention is a phosphatide, and this phosphatide preferably makes by chain alkyl acyl chlorides and the organic phospho acid derivatives reaction that preferably contains activity hydroxy or amino.
One aspect of the present invention provides the compound of the organic phospho acid with following formula:
Wherein,
R
3=contain>alkyl of 10 carbon atoms
R
4=H or CH
3
Preferred R
4It is methyl.
Alkyl acyl chloride has 10 or more carbon atoms, and preferably is no more than the chain length of about 20 carbon atoms, and specially suitable is the acyl chlorides of hexadecanoic acid and dodecylic acid.
Especially suitable phosphonate derivative is ethane-1-hydroxyl-1,1-di 2 ethylhexyl phosphonic acid (Etidronic acid) and 1 and 2 amino-ethyl phosphonic acids.
Therefore, the invention provides and a kind ofly be suitable as animal feedstuff additive, improve aquatic products on the other hand and look for the plain preparation method who absorbs and be used for the organo phosphorous compounds of the present invention of the ultra micro entrapped drug of drug release in the donor, it comprise with the acyl chlorides of longer chain fatty acid and the alkyl phosphonic acid derivative that contains active amino or hydroxyl in non-aqueous media (preferred chloroform) and react under the low temperature, with cold water washing and carry out drying subsequently.
Preferable reaction temperature remains below 5 ℃ and more preferably 3-5 ℃.
Preferred reactant is used by stoichiometric ratio simultaneously.
The present invention also provide above-mentioned as animal feedstuff additive, improve the pigment absorption of aquatic products thing or be used for the organic phosphoric acid that the medicine ultra micro of drug release is sealed in the donor.
Another aspect of the present invention provides can be as animal feedstuff additive and by ethane-1-hydroxyl-1, and the 1-di 2 ethylhexyl phosphonic acid is in non-aqueous media and be lower than the organo phosphorous compounds of the present invention that makes with the reaction of n-Hexadecane acyl chlorides under 5 ℃ the temperature.
Another aspect of the present invention provides the production method of the organic phospho acid derivative of the present invention that a kind of medicine ultra micro that is applicable to that drug disposition discharges seals, this method be with 1 or 2-amino-ethyl phosphonic acids and hexadecyl acyl chlorides be lower than in the non-aqueous media neutralization under 5 ℃ the temperature and react.
The following example illustrates but does not limit the present invention.
Add the solution of 206g Etidonic acid (ethane-1-hydroxyl-1,1-di 2 ethylhexyl phosphonic acid) in the 1L chloroform from a bite of three mouthfuls of glass reaction bottles of 5L that agitator is housed, and make this solution be cooled to 3-5 ℃.When temperature was remained on 3-5 ℃, another mouthful from reaction flask under vigorous stirring added 275g n-Hexadecane acyl chlorides.The hydrochloric acid that reaction is emitted is derived and is made it pass through the sodium hydroxide scrubber through the 3rd mouthful.After all the n-Hexadecane acyl chlorides finishes, continue to stir 60 minutes.With in the content impouring cold water in the reaction flask, separate and remove chloroform and the unreacted n-Hexadecane acyl chlorides that exists with n-Hexadecane carboxylic acid (a kind of wax) form when reaction finishes.Further with of the unreacted Etidonic acid of cold water washing products therefrom with the removal trace.Product is through repetitive scrubbing after-filtration and dry under vacuum.
The yield of product is 90% of a theoretical value.
Product is at about 70 ℃ of following water solubles and to obtain pH be 10.5 solution, and is qualitative by near infrared (NIR) spectrum shown in the accompanying drawing 1 (recording with NIR system series 5000 spectrometers) simultaneously.Can be sure of that product has following structure:
Ethane-1-hexadecanoyl-1, the 1-di 2 ethylhexyl phosphonic acid is described among the embodiment 9 below for the influence of fish pigment picked-up.
Embodiment 2
Substitute Etidonic acid with 125g2-amino-ethyl phosphonic acids and repeat embodiment 1 described method.
Product yield is 90% of a theoretical value.Thereby product is dissolved under 60 ℃ and obtains pH in the water is 3.33 solution.
Embodiment 3
Replace 2-amino-ethyl phosphonic acids to repeat embodiment 2 with 1-amino-ethyl phosphonic acids.Product yield is 60% and has as shown in Figure 3 NIR spectrum.Product is dissolved under 60 ℃ and obtains pH in the water to be 3.76 solution and to be sure of to have structure as follows:
Embodiment 4
Repeat embodiment 1 with 219g dodecanoyl chloro for the n-Hexadecane acyl chlorides.
Product yield is 23.2% of a theoretical value, and product is dissolved under 60 ℃, and to obtain pH in the water be 10.42 solution.Product is qualitative and be sure of to have structure as follows by NIR spectrum as shown in Figure 4:
Embodiment 5
Repeat embodiment 3 with 219g dodecanoyl chloro for the n-Hexadecane acyl chlorides.Product yield is 20% of a theoretical value.
Replace n-Hexadecane acyl chlorides and Etidronic acid or the reaction of 2-amino-ethyl phosphonic acids not to generate any valuable product with capryl(yl)chloride.
Embodiment 6
The preparation of 1-hexadecanoyl amino-ethyl phosphonic
Preparation divided for three steps carried out.Step 1:
With thiocarbamide (9.89g, 130mmol) add to acetaldehyde (18.57ml, 325mmol) and triphenyl phosphite (68.13ml in acetate 325mmol) (130ml) solution, stirs gained solution, and 80 ℃ down heating obtained orange solution in 1 hour.Add diacetyl oxide (325ml) and, obtain dark brown solution gained solution backflow 2 hours.Refluxed 8 hours then through careful 37% the hydrobromic acid aqueous solution (325ml) of dripping of condenser, and with gained solution, then cooling and rotary evaporation.Dark resistates is dissolved in the ethanol (260ml), and slowly to add methyl oxirane be 6 until pH.Should reinforced the aminophosphonic acid A of following listed reaction product be precipitated out rapidly.Make solid settlement and decantation supernatant liquid.Add new system ethanol (250ml) and with the of short duration backflow of mixture, cool off then and strain except that ethanol.Repeat such washing until sloughing major part is brown.At last that solid is dry under high vacuum, slightly be with look solid aminophosphonic acid A (8.23g, 50.6%), fusing point<290 ℃ (decomposition).
Step 2:
With phosphoramidic acid A (8.23g, 65.8mmol) and hexamethyldisilazane (55.5ml, mixture 263mmol) heat in 150-160 ℃ oil bath until all solids dissolving (2-5 hour).Steam to remove excessive hexamethyldisilazane and with the resistates distillation, obtain colorless oil and under 15mmHg boiling point be 140 N, O, O-front three silane derivative B (17.50g, 86%), the structure of this product is as shown in following reaction formula:
Step 3:
With hexadecanoic acid (13.18g, 51.4mmol) solution in anhydrous ethyl acetate (80ml) stirs down at-5 ℃, use successively subsequently triethylamine (17.15ml, 5.4mmol) and Vinyl chloroformate (5.57g 51.4mmol) handles, and back one component is dropping.The gained turbid mixture stirred 0.5 hour at-5 ℃, drip the solution of front three silane derivative B in ethyl acetate (35ml) then, and stirred the gained mixture 2 hours at uniform temp, and under not cooling situation, stirred 2 hours then, stirred 3 hours at 80 ℃ at last.From cooling mixture, remove volatile matter by rotary evaporation.Resistates is dissolved in the saturated sodium bicarbonate aqueous solution, with gained solution with 10% hcl acidifying to pH be 2, and leach sedimentary acylamino acid C.To remove remaining hexadecanoic acid, drying under high vacuum obtains white solid 1-hexadecanoyl amino-ethyl phosphonic acids C (16.0g, 86%) to solid crude product then with methanol wash.
The NMR spectrogram of the lysophospholipid of gained as shown in Figure 5.
Embodiment 7
The G-MEM (SigmaG5154) that adds 200mM L-glutaminate (Sigma G7513), 5%TSB (Sigma T8159) and the 10ml/L microbiotic/antimicrobial (Sigma A9909) of 10%FBS (Sigma F2442), 10ml/L with ordinary method and utilization cultivates BHK21 (clone 13) cell.At 37 ℃ and 5%CO
2Under carry out cell cultures.Above-mentioned clone is the European animal cell culture preservation center from using microbe that is positioned at Porton Down and research centre.
Above-mentioned cell is cultivated in 24 hole flat boards (Sigma M9655).All test triplicate.
The hole inner cell is exposed to from the C of 1 μ Ci of 75 μ Ci storing solutions, preparation Hanks balanced salt solution (SigmaH9394)
14Under the inulin.These cells also are exposed under embodiment 1 product of different concns simultaneously.Cultivate and take out medium after 1 hour.With attached cell subsequently with twice of HanksShi solution washing and use trypsinase-EDTA solution (Sigma T5775) pair cell to carry out trysinization again, under 1000rpm and in the Eppendorf that weighs the in advance pipe with cell centrifugation slabbing throw out.Use distilled water lysing cell pellet then.Recentrifuge Eppendorf pipe migrates out equal portions distilled water (100 μ) then, mixes with Sigma fluorine scintillation mixed solution (SigmaFluor Scintillation cocktail) (Sigma S4398) and utilizes the scintillometer reading.After Eppendorfs is weighed once more, the result is scaled DPM/mg cell weight.
The gained result is plotted as the figure shown in the accompanying drawing 6 and knows and demonstrates a kind of two-phase response, wherein, the flux that inulin enters cell under lower concentration reduces very much, but this flux increases significantly under higher dosage, and inulin is a kind of bigger compound and is not very typical being supposed to by the compound of preferential absorption simultaneously.Other big or small molecules also can observe identical effect.
Can draw the conclusion of the emulsion formation characteristic of relevant phosphatide and mixture of phospholipids from the mensuration of lecithin preparations emulsifying capacity.A kind ofly be used to measure that to surpass after 24 hours the empirical method of still stable O/w emulsion percentage amounts as described below:
Get 100ml distilled water and vegetables oil and place beaker.Add Yelkin TTS test sample (being generally 1g).Under 25 ℃, utilize high speed rotating mixing tank homogenizing mixture 1 minute.At once content is all transferred in the recorder jar and and placed 24 hours down at 25 ℃.Calculate the percentage amounts that remains oil-in-water emulsions after 24 hours.
Yelkin TTS compared to measure with 90% Yelkin TTS-10% embodiment, 1 product obtains following result:
Blank (Conto1): 0.0010
Yelkin TTS: 0.1948
The product of 90% Yelkin TTS-10% embodiment 1: 0.222
The above results shows that emulsifying capacity improved 12.3%.
Formed embodiment 2 products that comprise are described among the embodiment 8 below at the improved stability of interior oil-water mixture (Miscelle).Embodiment 8
Prepare liposome by following method:
14, about 30 seconds homogenizing prepares 1% water dispersion of embodiment 2 products under the 000rpm by the Utra-TurrexT25 homogenizer.Preparation two cover liposomes, in preparation, first kind of testing sample is to be formed by pure phosphatidylcholine (Yelkin TTS), and second kind be to make with 10% embodiment 2 products.Utilize Cecil Series2 instrument spectrophotometry liposome concentration under the 500NM wavelength.Liposomal formulation with microscopic examination to carry out spectrophotometric calibration.Oil-water mixture (miscelle) preparation was heated 30 minutes down in 30 heating 10 minutes and 3 hours and at 60 ℃ with water-bath.Analytical results is as follows:
10 minutes 3 hours 60 ℃-30 minutes
Yelkin TTS 1.31 1.288 0.975 Yelkin TTS+10% real 1.34 1.338 1.062
Execute example 2 products
Net added value 0.022% 3.88% 8.92%
The above results shows that oil-water mixture significantly increases in pyritous stability in the presence of the made phosphatide of the present invention.
Embodiment 9 ethane-1-hexadecanoyl-1,1-di 2 ethylhexyl phosphonic acid (Corbinol) is to the influence of salmon pigment picked-up
This test adopt 350 that come by pure Mowi crossability kind, to reach 24 monthly ages and average initial body weight through raising be that the first effluent of 1.2Kg is gone into Atlantic atlantic salmon.
Details are as follows for 5 kinds of used treatment facilities:
Four adjacent 5m proofing boxs of A-
A 12m breeding of B-case (seawater bath blank)
A B diameter 5.0m 12.0m tank wall height 1.2m 1.8m depth of water 0.9m 1.6m capacity 17.6m 180.0m makes up: make the cement box embedding on the ground of plane and undercoat level and smooth.What water-in: A was positioned at the single 100mm in case surface makes advancing of entry direction around tank edge
The mouth of a river.Current are per minute 2000L with butterfly valve control-peak flow.
What B was positioned at case surface single 200mm makes entry direction around tank edge
Water-in.Current are per minute with slide valve control-peak flow
2000L。Water outlet: A is positioned at middle part at the bottom of the case and the 0.6m that links to each other with the long rising pipe of 150mm *
0.6m the horizontal screen of diameter.
B be positioned at middle part at the bottom of the case and with 200mm long go out the 0.5m that bucket links to each other *
0.8m the horizontal screen of diameter.The water source:
A is in order in the autonomous salt solution header tank of a 11kw impeller pump (preparing and carrying usefulness) to draw water
Go into the casing water-in.Header tank by two lowest depth of independently drawing water is
Being lower than surperficial 3m pump system supplies water.Salt concn is 27ppt-31ppt.Water
Grizzly bar with 15mm before entering pump sieves.Water is not by casing once (no
Recirculation) and retention time be less than 1 hour.
The B casing is directly intake in main salt solution header tank.Ventilation: each case provides air by air diffuser separately from big agricultural gas blower.
The oxygen level that can effectively improve like this under the normal condition also will be in the event of failure of supplying water
Make fish continue a few hours of surviving under the barrier situation.Water level control: A is positioned at the external fixation pipe in the shared discharging pond adjacent with casing.
B external fixation pipe.Jump net (jump netting): around casing and the predation line be provided with 200mm high 85
% covering net (shade netting).The thrashing indication:
Low-water level buoyancy aid switch is installed in each casing.Be connected and whole day 24 with the center warning horn
Hour monitor.Automatic feeding:
Each case is all installed a timing that can be suspended in the 3kg capacity of water surface top, casing edge
Feeding apparatus.
Also with automatic feeding machine as a supplement come fish carried out 3 time feeding by artificial every day.The about 50% whole day food ration of calculating according to standard merchandise raising table is by manually providing.For increasing the body weight of fish,, can suitably adjust feeding speed in weekly.
Their body weight separately and definite cause of the death are taken out and write down to the fish of death at once.Anyly in process of the test be considered to essential disease treatment and should in all fish boxes, carry out, to reduce because the difference between the case that treatment may cause.
The current that keep the process casing are to guarantee that minimum dissolved oxygen level is 7.0mg/L.Detect the content of oxygen every day, and can will regulate current if desired to keep balance between fish box.Regularly scrub fish box with prevent tip long-pending and too much suspended solids.
Write down water temperature every day.
Adopt the following method fish of weighing:
Close the current that enter casing and make the depth of water reduce to 20cm.Utilization is installed in the intravital scatterer of case and keeps oxygen level.Then narcotic (being dissolved in the parathesin in the methylated spirit) is added to the water and makes the fish calmness.With net fish is dragged for to volume and to be 40L and to be equipped with in the well-bucket of 15L water, weigh with Salter 50kg suspension type spring balance in batches.Stress level and physical injury all remain on minimum like this.
The food of fish is as follows: food A-55ppm astaxanthin food B-55ppm astaxanthin+Corbinol (ethane-1-hexadecanoyl-1,1
-di 2 ethylhexyl phosphonic acid) food C-standard Trouw 75ppm astaxanthin (blank).
Divide 350 fishes equally in 5 casees (70 in every case).Case 1 and 3 usefulness food A feedings; Case 2 and 4 usefulness food B feedings (all being the A molding box); Sea water tank food C feeding (Type B case)
The pellet sizes of fish food is 6.5cm.
This test was carried out 36 days.
The gross weight of fish in each case of weighing when on-test and off-test.Carry out the sampling of the fish sample of corpse analysis after 4 weeks.Sample in the following time:
Get 10 fishes during on-test as base value:
In each case, get 10 fishes after 4 weeks;
When 36 days times finish, get all fishes that survive and make sample.
Utilize the astaxanthin level of HPLC analytic sample after selected immediately.
Therefore analyze after the 4th week, the 1st group of chromogenesis that demonstrates maximum range selected more fish and analyzed with HPLC from organizing 1.Get that 25% fish carries out that HPLC measures and all fishes carry out Roche Fan score value and determine.
Table 1 is listed the statistic by trial sheet.
Accompanying drawing 7 representative is with the diagram of the fish of each nursing of the three kinds of foods weight when the off-test.
Accompanying drawing 8 representative is with the diagram of the fish of each nursing of the three kinds of foods RocheFan score value when the off-test.
Result shown in the accompanying drawing 7 and 8 calculates with standard differentiate (derivation) method, and draws the difference of comparing the fish quantity of feeding with food A and B with the fish number of feeding with blank food.
Accompanying drawing 7 shows with nutrient substance (astaxanthin) and the common fish of raising of organic-phosphorus compound (Corbinol) has bigger increase than the weight with the fish that does not contain organic phosphorus compound food nursing.
Accompanying drawing 8 is represented to show higher Roche Fan score value with nutrient substance (astaxanthin) and the common fish ratio of raising of organic-phosphorus compound (Corbinol) with the fish that does not contain organic phosphorus compound food nursing.
Food kgs 15.8 14.2 15.5 18.0 0 efficiency of food conversion 0.92 0.96 1.17 0.91 0 mean temperatures 7.9 foods that average weight 1.393 1.421 1.373 1.517 1.230% increments 21.3 17.5 16.1 22.8 25.5 consumed than growth rate (% days) 0.54 0.45 0.410 0.57 0.63 when weight 00000 weight of gross weight 97.5 99.5 96.1 106.2 86.1 death increased by 17.1 14.8 13.3 19.7 17.5 initial average weights 1.149 1.210 1.183 1.236 0.980 end when quantity 70 70 70 70 70 initial gross weights 80.4 84.7 82.8 86.5 68.6 finished when the test statistics measuring tank 1234 seawater bath food A B A B C from date 27.2.95 Close Date 4.4.95 fates 36 36 36 36 36 starting quantities 70 70 70 70 70 dead quantity 00000 of table 1 embodiment 9 finished: A Trouw65,55ppm astaxanthin
B Trouw 65,55ppm astaxanthin+corbinol
The blank Trouw65 of C, the 75ppm astaxanthin
Food is directly provided by Trouw.
Corhinol (ethane-1-hexadecanoyl-1,1-di 2 ethylhexyl phosphonic acid)
Claims (16)
2. the organic phospho acid compound in the claim 1, wherein R
4Be methyl.
4. the organic phospho acid in the claim 2, it has following formula:
8. method for preparing the described organic phospho acid compound of claim 1, be included in the non-aqueous media and low temperature under make the acyl chlorides of longer chain fatty acid react, wash with water and dry with the alkyl phosphonic acid derivative that contains active amino or hydroxyl.
9. the method for preparing the organic phospho acid compound in the claim 8, wherein non-aqueous media is a chloroform.
10. the method for preparing the organic phospho acid compound in the claim 8 or 9, wherein temperature remains on below 5 ℃.
11. the method for preparing the organic phospho acid compound in the claim 10, wherein temperature range is 3-5 ℃.
12. each the method for preparing the organic phospho acid compound among the claim 8-11 contains in the chain of wherein said long-chain fat isoxazolecarboxylic acid and is less than 20 carbon atoms.
13. the method for preparing the organic phospho acid compound in the claim 12, wherein acyl chlorides is n-Hexadecane acyl chlorides or dodecane acyl chlorides.
14. each the method for preparing the organic phospho acid compound among the claim 8-13, wherein phosphonate derivative is ethane-1-hydroxyl-1,1-di 2 ethylhexyl phosphonic acid (Etidonic acid) or 1 or 2-amino-ethyl phosphonic acids.
15. each the method for preparing the organic phospho acid compound among the claim 8-14, wherein reaction reagent uses by stoichiometric ratio.
16. each organic phospho acid compound among the claim 1-7, it as the animal foodstuff additive, improve the pigment picked-up of aquatic products thing or be used for the medicine ultra micro that drug disposition discharges and seal.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9607583.3 | 1996-04-12 | ||
GBGB9607583.3A GB9607583D0 (en) | 1996-04-12 | 1996-04-12 | Organo phosphorous compounds |
GB9617729A GB2311991B (en) | 1996-04-12 | 1996-08-23 | Organo phosphorus compounds |
GB9617729.0 | 1996-08-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1218477A true CN1218477A (en) | 1999-06-02 |
Family
ID=26309109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN97194522A Pending CN1218477A (en) | 1996-04-12 | 1997-04-14 | Organo phosphorous compounds |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0892806A1 (en) |
CN (1) | CN1218477A (en) |
BR (1) | BR9708660A (en) |
GB (1) | GB2323089B (en) |
NO (1) | NO984671L (en) |
WO (1) | WO1997039004A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107602610A (en) * | 2017-09-09 | 2018-01-19 | 南通意特化工有限公司 | It is a kind of can reuse sulfuric acid wastewater containing organic phospho acid production technology |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0400988D0 (en) * | 2004-01-16 | 2004-02-18 | Oxoid Ltd | Therapeutically useful antibacterial compounds |
DE102004032781A1 (en) | 2004-01-23 | 2005-08-11 | Mcs Micro Carrier Systems Gmbh | New lipid-modified bis-phosphonic acid derivatives, useful e.g. for transporting therapeutic or diagnostic agents, with affinity for bone, also as corrosion inhibitors |
EP2344417B1 (en) * | 2008-10-03 | 2017-01-04 | Life Technologies Corporation | Nanocrystals with functional ligands |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2304156A (en) * | 1940-03-07 | 1942-12-08 | Du Pont | Organic compound and process of preparing the same |
DE2530139C3 (en) * | 1975-04-30 | 1979-06-21 | Joh. A. Benckiser Gmbh, 6700 Ludwigshafen | N-acyl-1-aminoalkane-1,1-diphosphonic acids, their preparation and use |
DE2651048A1 (en) * | 1976-11-09 | 1978-05-18 | Hoechst Ag | PLASTIC DISPERSION WITH HIGH WET ADHESION AND METHOD FOR THEIR PRODUCTION |
JP2612619B2 (en) * | 1988-12-14 | 1997-05-21 | 財団法人相模中央化学研究所 | Transdermal absorption enhancer consisting of phosphorus-containing compound |
EP0550385A1 (en) * | 1991-12-19 | 1993-07-07 | Ciba-Geigy Ag | Oral pharmaceutical compositions containing derivatives of methane-diphosphonic acid and 18-crown-6 ethers |
GB2267033B (en) * | 1992-03-07 | 1996-01-24 | David Garnett | Lysophospholipid Animal Feed Supplement |
US5523430A (en) * | 1994-04-14 | 1996-06-04 | Bristol-Myers Squibb Company | Protein farnesyl transferase inhibitors |
-
1996
- 1996-08-23 GB GB9726184A patent/GB2323089B/en not_active Expired - Fee Related
-
1997
- 1997-04-14 BR BR9708660-6A patent/BR9708660A/en not_active Application Discontinuation
- 1997-04-14 EP EP97916556A patent/EP0892806A1/en not_active Ceased
- 1997-04-14 CN CN97194522A patent/CN1218477A/en active Pending
- 1997-04-14 WO PCT/GB1997/001020 patent/WO1997039004A1/en not_active Application Discontinuation
-
1998
- 1998-10-06 NO NO984671A patent/NO984671L/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107602610A (en) * | 2017-09-09 | 2018-01-19 | 南通意特化工有限公司 | It is a kind of can reuse sulfuric acid wastewater containing organic phospho acid production technology |
Also Published As
Publication number | Publication date |
---|---|
GB2323089A8 (en) | 1998-09-24 |
GB2323089A (en) | 1998-09-16 |
EP0892806A1 (en) | 1999-01-27 |
GB2323089B (en) | 1999-02-10 |
NO984671D0 (en) | 1998-10-06 |
BR9708660A (en) | 2000-01-04 |
NO984671L (en) | 1998-12-04 |
WO1997039004A1 (en) | 1997-10-23 |
GB9726184D0 (en) | 1998-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103917636A (en) | Algal lipid compositions and methods of preparing and utilizing the same | |
WO2007074976A1 (en) | Feed for bee mite control and a method of its preparation | |
EP0390819A4 (en) | Mass production in liquid culture of insect-killing nematodes | |
WO2006054183A3 (en) | Enzymatically synthesized marine phospholipids | |
CN1745725A (en) | Artificial culture of shrimp parents | |
CN1218477A (en) | Organo phosphorous compounds | |
KR101483798B1 (en) | Production of acid propionates | |
CN1197846C (en) | Carotenoid ester | |
CN1290408C (en) | Ecological no-hibernation snake cultivating method | |
JP2002223708A (en) | Feed composition for broiler and method for rearing broiler | |
EP2397240A1 (en) | Method for removing phorbol ester from organic material, method for producing organic material having high protein content, organic material having high protein content, method for producing feed, and feed | |
Miller et al. | Dietary calcium levels in pre-lay and lay diets in Leghorn pullets | |
TW201130412A (en) | Manufacturing method of nutritional substance containing housefly pupae | |
CN1019298B (en) | Plant protection agent for control of fungi and bacteria | |
CN113974017B (en) | Feed additive for enriching phosphatidylethanolamine type DHA in eggs, and preparation method and application thereof | |
CN108218739A (en) | Butyryl glutamate derivatives and combinations thereof and application | |
CN105146217B (en) | A kind of crustacean aquaculture growth-promoting additive and preparation method thereof | |
EP0427783A4 (en) | Silicon containing reaction product | |
JP5621204B2 (en) | Anti-vascular aging agent | |
KR102480651B1 (en) | Process for breeding animal with organic germanium-ion water | |
CN1124272C (en) | Podophyllotoxin compound and application thereof in killing insects | |
CN106332846A (en) | Breeding method for reducing amount of lead element in manure absorbed and concentrated by earthworm | |
JPS60196184A (en) | Cultivation of euglena | |
CN106831587A (en) | Pyrazol acid amide compounds and preparation method and application | |
CN1050029C (en) | Thiophosphoryl amide ester herbicide for paddy fields and dry farmland |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1052589 Country of ref document: HK |